Primary Menu

Pharmaceuticals to Financial Services: How Anti-Corruption is Remaking China’s Markets

For over a year, the Chinese government has waged war against corruption battling it in boardrooms and courtrooms, consuming both “tigers” and “flies”. Although it is clear that officials are serious about this fight, many in the corporate world harbor fears surrounding the remaining unknowns, particularly among those in the healthcare industry, which has been rocked by numerous ongoing anti-corruption actions.

Shanghai, China, February 19, 2014 /ChinaNewswire.com/ - The 6th Anti-Corruption Compliance in China Summit 2014 will offer guidance from leaders in the government fight against corruption such as the SAIC, MPS, and NHFPC, as well as those in the legal and business community who have overcome the obstacles of working amid this chaos. Among the events major discussion points will be third-party investigations from within a company or from the outside, managing company control systems, keeping sales and compliance working with the same goals, and managing executive-level risk.

These are already determined to be crucial issues with enforcement bodies in China, the US and UK focusing aggressive enforcement on the actions of third parties, with the integrity of corporate compliance systems weighing heavily in court decisions of liability. As well, corruption watchers await results of U.S. FCPA cases involving banking and hiring practices. Not about to wait and see, delegates at the two-day summit will be devoting one of the event’s open forum panel discussions to determining the best way to ensure clean, transparent hiring policies with several leading experts from the financial industry.

The Anti-Corruption Compliance China Summit, presented by Duxes (Shanghai) Business Consulting, has grown over the past six years to become the premier platform for bringing together experts from all sides of corporate law to mold the global conversation on anti-corruption policy for the year to come.